Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-13 Option Award | 2023-06-15 6:26 pm | N/A 2033-06-12 | Stoke Therapeutics Inc. | STOK | Smith Julie Director | 19,441 | $0 | 19,441 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-02 9:10 pm | 2023-06-01 2030-05-31 | EXELIXIS INC. | EXEL | Smith Julie Director | 44,087 | $0 | 44,087 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 5:00 pm | N/A 2032-06-06 | Stoke Therapeutics Inc. | STOK | Smith Julie Director | 21,000 | $0 | 21,000 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-27 9:12 pm | 2022-05-26 2029-05-25 | EXELIXIS INC. | EXEL | Smith Julie Director | 42,422 | $0 | 42,422 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-25 5:02 pm | N/A 2031-06-07 | Stoke Therapeutics Inc. | STOK | Smith Julie Director | 11,650 | $0 | 11,650 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 8:08 pm | N/A N/A | EXELIXIS INC. | EXEL | Smith Julie Director | 16,424 | $0 | 32,725 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:31 pm | N/A 2020-06-02 | Stoke Therapeutics Inc. | STOK | Smith Julie Director | 29,555 | $0 | 29,555 (Direct) | View |
Ownership | 2020-06-05 5:10 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Smith Julie Director | 0 | $0 | 0 (Direct) | View |
| 2020-05-21 Option Award | 2020-05-22 9:06 pm | N/A N/A | EXELIXIS INC. | EXEL | Smith Julie Director | 15,538 | $0 | 16,301 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:37 pm | N/A 2027-01-01 | Audentes Therapeutics Inc. | BOLD | Smith Julie Director | 53,200 | $0 | 0 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-24 8:47 pm | 2019-05-23 2026-05-22 | EXELIXIS INC. | EXEL | Smith Julie Director | 42,641 | $0 | 42,641 (Direct) | View |